Cargando…

Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses

PURPOSE: To investigate if a traditional Chinese medicine formulation, called “Yiqihuoxue” (YQHX), could improve diabetic atherosclerosis (DA) and explore potential mechanisms based on DNA methylation. METHODS: Apolipoprotein E-knockout mice were administered streptozotocin (50 mg/d, i.p.) for 5 day...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qing-Bing, Chen, Yao, Zhang, Yan, Li, Dan-Dan, Wang, Hong-Qin, Jia, Zi-Jun, Jin, Yu, Xu, Feng-Qin, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754469/
https://www.ncbi.nlm.nih.gov/pubmed/35035227
http://dx.doi.org/10.2147/JIR.S335374
_version_ 1784632279352475648
author Zhou, Qing-Bing
Chen, Yao
Zhang, Yan
Li, Dan-Dan
Wang, Hong-Qin
Jia, Zi-Jun
Jin, Yu
Xu, Feng-Qin
Zhang, Ying
author_facet Zhou, Qing-Bing
Chen, Yao
Zhang, Yan
Li, Dan-Dan
Wang, Hong-Qin
Jia, Zi-Jun
Jin, Yu
Xu, Feng-Qin
Zhang, Ying
author_sort Zhou, Qing-Bing
collection PubMed
description PURPOSE: To investigate if a traditional Chinese medicine formulation, called “Yiqihuoxue” (YQHX), could improve diabetic atherosclerosis (DA) and explore potential mechanisms based on DNA methylation. METHODS: Apolipoprotein E-knockout mice were administered streptozotocin (50 mg/d, i.p.) for 5 days and fed a high-fat diet for 16 weeks. Mice were divided randomly into DA model, rosiglitazone, as well as low-, medium-, and high-dose YQHX groups. Ten healthy C57BL/6J mice were the control group. Serum levels of fasting insulin, blood glucose, homeostasis model-insulin resistance index (HOMA-IR), serum lipids, and inflammatory factors were analyzed after the final treatment. Aorta tissues were collected for staining (hematoxylin and eosin, and Oil red O). Genomic DNA was extracted for methyl-capture sequencing (MC-seq). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) databases were used to analyze differentially methylated genes. Pyrosequencing was used to verify MC-seq data. RESULTS: Low-dose and high-dose YQHX could reduce the HOMA-IR (P < 0.05). Low-dose YQHX reduced expression of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), TNF-α, andI L-6 in serum compared with that in the model group (P < 0.05). Medium-dose YQHX decoction inhibited the expression level of TNF-α (P < 0.05). High-dose YQHX decreased the expression level of IL-6 (P < 0.05). Staining also showed the anti-atherosclerosis effects of YQHX (P < 0.05). MC-seq revealed many abnormally hypermethylated and hypomethylated genes in DA mice compared with those in the control group. KEGG database analysis showed that the hypermethylated genes induced by YQHX treatment were related to pathways in cancer, Hippo signaling, and mitogen activated protein kinase. The network analysis suggested that the hypermethylated genes epidermal growth factor receptor(Egfr) and phosphoinositide-3-kinase regulatory subunit 1(Pik3r1) induced by YQHX treatment had important roles in DA. Pyrosequencing revealed that YQHX treatment increased methylation of AKT1, Nr1h3 and Fabp4 significantly (P < 0.05). CONCLUSION: YQHX decoction had positive treatment effects against DA, because it could regulate aberrant hypomethylation of DNA.
format Online
Article
Text
id pubmed-8754469
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87544692022-01-13 Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses Zhou, Qing-Bing Chen, Yao Zhang, Yan Li, Dan-Dan Wang, Hong-Qin Jia, Zi-Jun Jin, Yu Xu, Feng-Qin Zhang, Ying J Inflamm Res Original Research PURPOSE: To investigate if a traditional Chinese medicine formulation, called “Yiqihuoxue” (YQHX), could improve diabetic atherosclerosis (DA) and explore potential mechanisms based on DNA methylation. METHODS: Apolipoprotein E-knockout mice were administered streptozotocin (50 mg/d, i.p.) for 5 days and fed a high-fat diet for 16 weeks. Mice were divided randomly into DA model, rosiglitazone, as well as low-, medium-, and high-dose YQHX groups. Ten healthy C57BL/6J mice were the control group. Serum levels of fasting insulin, blood glucose, homeostasis model-insulin resistance index (HOMA-IR), serum lipids, and inflammatory factors were analyzed after the final treatment. Aorta tissues were collected for staining (hematoxylin and eosin, and Oil red O). Genomic DNA was extracted for methyl-capture sequencing (MC-seq). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) databases were used to analyze differentially methylated genes. Pyrosequencing was used to verify MC-seq data. RESULTS: Low-dose and high-dose YQHX could reduce the HOMA-IR (P < 0.05). Low-dose YQHX reduced expression of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), TNF-α, andI L-6 in serum compared with that in the model group (P < 0.05). Medium-dose YQHX decoction inhibited the expression level of TNF-α (P < 0.05). High-dose YQHX decreased the expression level of IL-6 (P < 0.05). Staining also showed the anti-atherosclerosis effects of YQHX (P < 0.05). MC-seq revealed many abnormally hypermethylated and hypomethylated genes in DA mice compared with those in the control group. KEGG database analysis showed that the hypermethylated genes induced by YQHX treatment were related to pathways in cancer, Hippo signaling, and mitogen activated protein kinase. The network analysis suggested that the hypermethylated genes epidermal growth factor receptor(Egfr) and phosphoinositide-3-kinase regulatory subunit 1(Pik3r1) induced by YQHX treatment had important roles in DA. Pyrosequencing revealed that YQHX treatment increased methylation of AKT1, Nr1h3 and Fabp4 significantly (P < 0.05). CONCLUSION: YQHX decoction had positive treatment effects against DA, because it could regulate aberrant hypomethylation of DNA. Dove 2022-01-08 /pmc/articles/PMC8754469/ /pubmed/35035227 http://dx.doi.org/10.2147/JIR.S335374 Text en © 2022 Zhou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhou, Qing-Bing
Chen, Yao
Zhang, Yan
Li, Dan-Dan
Wang, Hong-Qin
Jia, Zi-Jun
Jin, Yu
Xu, Feng-Qin
Zhang, Ying
Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
title Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
title_full Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
title_fullStr Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
title_full_unstemmed Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
title_short Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
title_sort hypermethylation effects of yiqihuoxue decoction in diabetic atherosclerosis using genome-wide dna methylation analyses
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754469/
https://www.ncbi.nlm.nih.gov/pubmed/35035227
http://dx.doi.org/10.2147/JIR.S335374
work_keys_str_mv AT zhouqingbing hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT chenyao hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT zhangyan hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT lidandan hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT wanghongqin hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT jiazijun hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT jinyu hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT xufengqin hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses
AT zhangying hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses